Resonance Health LtdASX: RHT

Liver Fibrosis Device Webinar Presentation

Oct 27, 2026 at 9:36 PM EDT · Issued by Resonance Health Ltd via ASX

Filed with ASX · Oct 27, 2026 at 9:36 PM EDT

On 6ix: 6ix.com/news/liver-fibrosis-device-webinar-presentation-1

ASX Announcement – 28 October 2026 MRI LIVER FIBROSIS DEVICE CLINICAL TRIAL PRELIMINARY RESULTS WEBINAR Resonance Health Ltd (Resonance or Company) (ASX: RHT) has today released “Preliminary results of MRI Liver Fibrosis Device clinical trial investor presentation”, enclosed with this...

View Attachment

6ix is reading this filing.

Resonance Health Ltd on 6ix

In the deck

Resonance Health — Corporate Update (October 2026)31 slidesOct 28, 2026

Earlier from Resonance Health

Investor Presentation Liver Fibrosis Device & Capital RaiseOct 26
$6.0 Million Placement OversubscribedOct 26
Liver Fibrosis Device - EPoC Study ResultsOct 26
Trading HaltOct 22
Global Strategic Alliance & MSA with Image Analysis GroupSep 16

All Resonance Health news releases

Follow Resonance Health into a list and get an email when it puts out news.

Follow Resonance Health